Belirle ve Unut Gelirine En Yakın Şey: Gönül Rahatlığı İsteyen Emekliler için 5 Temettü Kralı

The Closest Thing to Set-It-and-Forget-It Income: 5 Dividend Kings for Retirees Who Want Peace of Mind

Chris Lange

Sat, September 12, 2026 at 5:50 PM GMT+3 8 min read

Quick Read

• PG and JNJ have raised dividends for 70 and 64 straight years, each generating roughly $16 to $20 billion in annual free cash flow with near-bond-like volatility.

• EMR's free cash flow surged 35% year over year, while GPC delivers the group's highest yield at 3.09% but a planned 2027 company split could reshape its dividend policy.

• Just released. Our analysts combed the entire stock market and named the ten best stocks to buy right now, and Johnson & Johnson didn't make the cut. Enter your email to see the names that beat JNJ. The report is free. Enter your email and see if any of your stocks made the cut.

Dividend Kings, the elite group of US companies with at least 50 consecutive years of annual dividend increases, are the closest thing income investors get to a buy-once-and-forget holding. The bar is brutal: recessions, wars, oil shocks, pandemics, and management changes all had to be survived without a single missed raise. Consider Procter & Gamble (NYSE:PG), whose latest board action marked the 70th consecutive year of dividend increases and 136th consecutive year of dividend payments. Five names anchor this list, each with a payout backed by real cash flow rather than balance-sheet trickery.

Procter & Gamble (PG)

P&G currently yields 2.99% on a forward annualized dividend of $4.354 per share, with the most recent quarterly payment of $1.0885 paid August 17, 2026.

Fiscal 2026 free cash flow reached $15.84 billion, up 12.74% year over year, on operating cash flow of $19.56 billion. Against that, P&G plans roughly $10 billion in dividends and $5 billion in buybacks in FY2027, so free cash flow covers the payout with room to spare. The balance sheet holds $9.94 billion in cash against $54.31 billion of shareholders' equity, and the dividend streak is the longest on this list at 70 straight years.

Free Report, Just Released

Why Didn't JNJ Make The Top 10 List?

24/7 Wall St has helped investors make money for over two decades, and our top analysts just finished ranking the definitive Top 10 Stocks To Buy Now. Not the ten biggest companies. Not the ten everyone is arguing about. The ten best stocks to buy right now.

And JNJ didn't make the cut!

The report is free, and you can see why we think each stock is a top investment today.

Enter Your Email and See the Ten →

The bull case for income investors is boring in the best way: soap, razors, diapers, and detergent generate durable cash across cycles, and a beta of 0.377 means the stock moves far less than the market during drawdowns. Guidance calls for core EPS in-line to +3% versus FY2026's $6.89 base, enough to keep raises coming.

Risk: Management flagged a roughly $1 billion after-tax commodity, energy, and transport headwind, an approximate 8% drag in FY2027, alongside weak volumes in Family Care and Greater China.

Johnson & Johnson (JNJ)

Johnson & Johnson (NYSE:JNJ) pays a quarterly dividend of $1.34, an annualized forward rate of $5.36, for a current yield of 1.97%. The April raise of 3.1% marked the 64th consecutive year of dividend increases.

Full-year 2025 free cash flow reached $19.70 billion on $94.19 billion in revenue, and Q1 FY2026 revenue expanded 9.9% year over year to $24.06 billion. JNJ carries one of the strongest credit profiles in the S&P 500, and beta sits at 0.235, close to bond-like volatility.

Bull case: Innovative Medicine oncology drugs are compounding fast, with DARZALEX at $3.96 billion (+22.5%), CARVYKTI +62.1%, and TREMFYA +68.3%, and MedTech Cardiovascular grew 13%. FY2026 guidance was raised to adjusted EPS of $11.45 to $11.65, easily funding the dividend. Shares have also rewarded holders, up 52.13% over the past year.

Risk: STELARA biosimilar erosion is real, with sales down 59.7% as generics enter, and litigation charges hit $330 million in Q1.

Lowe's Companies (LOW)

Lowe's Companies (NYSE:LOW) yields 2.47% on a forward annualized dividend of $5.00. The most recent quarterly payment rose to $1.25 from $1.20, and the payment record extends back to January 1999 without interruption, with the payout climbing from roughly $0.03 per quarter in 1999 to today's level.

Free cash flow yield sits at 6.93%, well above the dividend yield, and the P/FCF ratio is 14.43. Interest coverage of 6.65x and net debt to EBITDA of 3.54x are healthy for a home-improvement retailer. Negative shareholders' equity of -$7.44 billion in Q2 FY27 looks alarming at first glance but reflects aggressive buybacks over years.

The bull case: Q2 FY2027 delivered revenue of $25.96 billion (+8.3%) and adjusted EPS of $4.40 versus a $4.22 consensus, the fifth straight beat, marking a fifth consecutive quarter of positive comps. Online sales grew 15.7%, and Pro contractor demand is strong. At a P/E of 17, this is one of the cheapest large-cap dividend growers around.

Risk: The stock is down 26.27% over the past year as DIY discretionary spending weakens and tariff uncertainty pressures margins.

Emerson Electric (EMR)

Emerson Electric (NYSE:EMR) yields 1.48%, the lowest in this group, on an annualized forward dividend of $2.22. The quarterly rate rose to $0.555 from $0.5275 in early 2026, extending a payment history that runs back to February 1999 in the record.

The coverage for Emerson is arguably the strongest out of the group here. Q3 FY2026 free cash flow reached $1.32 billion, up 35.4% year over year, on revenue of $4.87 billion (+7.0%). FY2026 guidance calls for roughly $3.6 billion in free cash flow, against a capital return plan of $1.2 billion in dividends and $1.0 billion in buybacks. Shareholders' equity of $20.38 billion and cash of $2.18 billion anchor a solid balance sheet.

The bull case: Emerson is a pure-play automation company benefiting from reshoring and industrial capex. Software & Systems grew 11% and Test & Measurement grew 23%, while adjusted segment EBITA margin expanded to 28.5% (+140 basis points). Shares are up 15.97% year to date.

Risk: Trailing P/E is 32, so the valuation carries less margin for a growth stumble than PG or JNJ, and FX plus Middle East exposure add turbulence.

Genuine Parts Company (GPC)

Genuine Parts Company (NYSE:GPC) yields 3.09%, the highest in this group, on a forward annualized dividend of $4.25. The quarterly payout rose to $1.0625 from $1.03 earlier this year. The dividend history shows a clean annual step-up every year visible in the record, from $0.26 per quarter in 1999 to today.

FY2026 guidance calls for adjusted diluted EPS of $7.50 to $8.00 and free cash flow of $550 million to $700 million, comfortably above the dividend obligation. GAAP EPS is being weighed by $92.61 million pre-tax restructuring and separation costs in Q2. The balance sheet holds $559 million in cash and $4.54 billion in equity.

The bull case: Q2 revenue rose 6.0% to $6.54 billion, with Industrial comps up 6.1% and margins expanding. NAPA-branded parts have deep, durable end-market demand.

Risk: The planned separation into two independent public companies (Global Automotive and Global Industrial), targeted Q1 2027, could reshape the dividend policy of either successor. Income investors owning GPC for the streak should watch capital-allocation guidance from the spin-out entities closely.

These five names together give retirees a spread across consumer staples, healthcare, home improvement retail, industrial automation, and parts distribution, with every payout backed by demonstrable free cash flow rather than debt-funded promises. PG and JNJ deliver the verified multi-decade streak with the lowest volatility, LOW offers the deepest valuation cushion, EMR contributes the fastest cash-flow growth, and GPC provides the highest yield of the bunch. Buy-and-hold portfolios built around this quality tier tend to compound quietly, and the raises tend to arrive regardless of what the headlines say (we ranked ten Dividend Kings by valuation right now in a free report you can grab here).

Got $1,000? Before You Buy JNJ, Read This

If you have cash sitting in your account right now, give this two minutes. After more than two decades of helping investors beat the market, our top analysts at 24/7 Wall St. put together a definitive report on the Top 10 Stocks To Buy Today. And JNJ wasn't one of them.

They combed the entire market. It's not 10 ideas, not 10 stocks everyone is talking about, it's what their research points to as the 10 best stocks to buy right now, and it's free. Read more here and see which stocks made the list -->>

Contact editorial@247wallst.com for any questions or corrections.